Literature DB >> 2280648

[Progress in the diagnosis and therapy of C cell carcinoma of the thyroid gland].

A Frilling1, P E Goretzki, H D Röher.   

Abstract

Between 1986 and 1989 172 patients were operated on thyroid cancer. Twenty-nine (17%) of them had a medullary carcinoma. In 20 of these patients (69%) the carcinoma occurred in a sporadic and in 9 (31%) patients in a familial form. Eighteen patients (62%) had to be operated because of tumor recurrence and in 4 of them additional surgery was necessary because of distant metastases. Due to tumor recurrence 7 patients underwent multiple operations during the above period. Adequate first operation was performed only in 6 patients (33%). Based on family screening a carcinoma was diagnosed in 4 patients in its occult stage. Diagnostic methods include biochemical and imaging methods. Calcitonin is the most sensitive tumor marker. Basal and stimulated serum calcitonin analysis provides a very efficient method to detect medullary carcinoma in early tumor stage and to treat the disease curatively. DNA-analysis improves early diagnosis of persons at risk.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2280648     DOI: 10.1007/bf00185215

Source DB:  PubMed          Journal:  Langenbecks Arch Chir        ISSN: 0023-8236


  28 in total

1.  Medullary thyroid carcinoma: prognosis of familial versus sporadic disease and the role of radiotherapy.

Authors:  N A Samaan; P N Schultz; R C Hickey
Journal:  J Clin Endocrinol Metab       Date:  1988-10       Impact factor: 5.958

2.  Family screening in medullary thyroid carcinoma presenting without a family history.

Authors:  B A Ponder; N Finer; R Coffey; C L Harmer; M Maisey; M G Ormerod; M E Pembrey; M A Ponder; P Rosswick; S Shalet
Journal:  Q J Med       Date:  1988-04

3.  Value of venous catheterization and calcitonin studies in the treatment and management of clinically inapparent medullary thyroid carcinoma.

Authors:  M D Ben Mrad; P Gardet; A Roche; P Rougier; C Calmettes; P Motte; C Parmentier
Journal:  Cancer       Date:  1989-01-01       Impact factor: 6.860

4.  Screening for multiple endocrine neoplasia type 2a with DNA-polymorphism analysis.

Authors:  H Sobol; S A Narod; Y Nakamura; A Boneu; C Calmettes; D Chadenas; G Charpentier; J F Chatal; N Delepine; M J Delisle
Journal:  N Engl J Med       Date:  1989-10-12       Impact factor: 91.245

5.  Histopathologic characteristics and nuclear DNA content as prognostic factors in medullary thyroid carcinoma. A nationwide study in Sweden. The Swedish MTC Study Group.

Authors:  U Bergholm; H O Adami; G Auer; R Bergström; M Bäckdahl; L Grimelius; G Hansson; O Ljungberg; E Wilander
Journal:  Cancer       Date:  1989-07-01       Impact factor: 6.860

6.  [Multiple endocrine neoplasias--MEN type I and II--the clinical picture, diagnostic and surgical-therapeutic strategy].

Authors:  H D Röher; D Branscheid
Journal:  Chirurg       Date:  1986-09       Impact factor: 0.955

7.  Leu-M1 immunoreactivity and prognosis in medullary carcinomas of the thyroid gland.

Authors:  S Schröder; W Schwarz; W Rehpenning; H Dralle; V Bay; W Böcker
Journal:  J Cancer Res Clin Oncol       Date:  1988       Impact factor: 4.553

8.  Diagnostic and prognostic values of carcinoembryonic antigen in medullary carcinoma of the thyroid.

Authors:  M F Saad; H A Fritsche; N A Samaan
Journal:  J Clin Endocrinol Metab       Date:  1984-05       Impact factor: 5.958

9.  Assignment of multiple endocrine neoplasia type 2A to chromosome 10 by linkage.

Authors:  N E Simpson; K K Kidd; P J Goodfellow; H McDermid; S Myers; J R Kidd; C E Jackson; A M Duncan; L A Farrer; K Brasch
Journal:  Nature       Date:  1987 Aug 6-12       Impact factor: 49.962

10.  Results of early thyroidectomy for medullary thyroid carcinoma in children with multiple endocrine neoplasia type 2.

Authors:  R L Telander; D Zimmerman; J A van Heerden; G W Sizemore
Journal:  J Pediatr Surg       Date:  1986-12       Impact factor: 2.545

View more
  1 in total

1.  European endocrine surgery in the 150-year history of Langenbeck's Archives of Surgery.

Authors:  Henning Dralle; A Machens
Journal:  Langenbecks Arch Surg       Date:  2010-03-09       Impact factor: 3.445

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.